...
首页> 外文期刊>Acute Medicine & Surgery >Euglycemic diabetic ketoacidosis due to a strict low‐carbohydrate diet during treatment with sodium‐glucose cotransporter 2 inhibitors
【24h】

Euglycemic diabetic ketoacidosis due to a strict low‐carbohydrate diet during treatment with sodium‐glucose cotransporter 2 inhibitors

机译:由于钠 - 葡萄糖Cotroangerport 2抑制剂治疗期间,由于严格的低碳水化合物饮食而导致的可临时血糖糖尿病

获取原文
           

摘要

Background Euglycemic diabetic ketoacidosis is a critical clinical presentation that can occur during treatment with sodium‐glucose cotransporter 2 inhibitors. However, little is known regarding how a low‐carbohydrate diet in combination with this treatment can increase the risk for this condition. Here, we report a case of euglycemic diabetic ketoacidosis in a patient treated with sodium‐glucose cotransporter 2 inhibitors after initiation of a low‐carbohydrate diet. Case Presentation A 54‐year‐old woman who was taking canagliflozin was transferred to our hospital with severe dyspnea. She had been started on a strict low‐carbohydrate diet for 6?days before admission. Laboratory evaluation revealed severe ketoacidosis and a blood glucose level of 196?mg/dL. After her symptoms improved, she was diagnosed with type 1 diabetes mellitus. Conclusion Although low‐carbohydrate diets are recommended for patients with diabetes mellitus, physicians should exercise great caution in recommending low‐carbohydrate diets to patients undergoing treatment with sodium‐glucose cotransporter 2 inhibitors.
机译:背景技术糖尿病酮酸癌递液是一种关键的临床介绍,其在用钠 - 葡萄糖Cotroangerporper 2抑制剂处理过程中可能发生。然而,关于低碳水化合物饮食如何结合这种治疗的情况毫无熟悉,可以增加这种情况的风险。在这里,我们在发起低碳水化合物饮食后,通过钠 - 葡萄糖Cot转发器2抑制剂治疗的患者中报告了患者中的患者中的患者患者的病例。案例介绍一名正在服用蜜月的54岁女性被严重呼吸困难转移到我们院的医院。在入院前6个月,她已经开始严格的低碳水化合物饮食。实验室评估显示严重的酮症病症和196μg/ d1的血糖水平。在她的症状改善后,她被诊断出患有1型糖尿病。结论虽然建议对糖尿病患者推荐低碳水化合物饮食,但医生应在推荐用钠葡萄糖COTRANSPORPOR 2抑制剂进行治疗的患者的低碳水化合物饮食中进行大规模谨慎。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号